Narrative review compares ICG and conventional mapping techniques for SLN detection in melanoma, suggesting enhanced accuracy and safety.
Accurate sentinel lymph node (SLN) mapping is essential for staging melanoma and guiding adjuvant therapy. Conventional mapping uses technetium-99m (Tc-99m) radiocolloid ± blue dye. Near-infrared fluorescence with indocyanine green (ICG) offers real-time, radiation-free visualization but varies in transcutaneous performance. This review synthesizes contemporary evidence comparing ICG to Tc-99m and blue dye for SLN detection in melanoma, highlighting anatomic, technical, and safety considerations relevant to surgical workflow. Narrative review of prospective series, head-to-head studies, and recent systematic reviews/meta-analyses evaluating SLN identification rates, node-level detection, transcutaneous vs. intraoperative fluorescence, false-negative considerations, and adverse events, with special attention to head/neck melanoma and dual-tracer strategies. ICG achieves high patient-level SLN identification (≈79–100%), comparable to Tc-99m (≈86–100%) and consistently superior to blue dye alone. Dual-tracer approaches (ICG + Tc-99m or ICG + blue dye) frequently report near-universal detection and practical reductions in missed nodes. Transcutaneous fluorescence through intact skin is variable, limited by near-infrared penetration and BMI, whereas intraoperative fluorescence after a small incision is highly reliable and expedites dissection. Head/neck basins particularly benefit from real-time fluorescence to delineate complex channels and confirm first-echelon nodes. ICG demonstrates an excellent safety profile with rare hypersensitivity, avoids radiation exposure, and integrates smoothly with gamma-probe guidance. Adoption barriers include heterogeneous dosing/timing, equipment cost, and lack of standardized reporting. ICG fluorescence is a robust adjunct to standard SLN mapping, offering intraoperative “visual GPS” especially valuable in head/neck melanoma. Current evidence supports ICG as a complement for radiocolloid mapping.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: